The Reverse Mullet Healthcare Podcast

Groundbreaking Patient Engagement and Consumer Insights Report Results with Dr. Arti Masturzo

BP2 Health

On the Road Edition - Live at ViVE, Episode 2

With her mullet game strong and healthcare innovation insights even stronger, Dr. Arthi Masturzo, Chief Medical Officer at CCS, captivates us with tales from the frontlines of patient engagement. As we laugh our way through day three of VIVE 2024, Dr. Masturzo, alongside your @bp2health hosts Ellen Brown and Dave Pavlik, unveils her passion for integrating digital health technologies and AI into patient care, proving that the future of healthcare is as exciting as the hairdos at an '80s rock concert and special Billy Idol concert for VIVE attendees.

Enjoy the revelations, where over 85% patient engagement isn't just a number—it's a reality for CCS under Dr. Masturzo's watch. This episode dives into the deep end of value-based care, patient interactions, and shares key findings from a groundbreaking study poised to revolutionize the care of individuals with diabetes and chronic conditions.

Speaker 1:

All right. So here we are, day three of Vive 2024.

Speaker 2:

And for the on-the-road edition of the Reverse Mullet Healthcare Podcast.

Speaker 1:

I'm Ellen Brown and I'm Dave Pavlik, and today we are joined by Dr Arthi Masturzo. Perfect pronunciation. I'm impressed. You did great.

Speaker 2:

Everybody listening. We had to practice. I had to practice several times. Like many times more than several, yes, but it made it really fun and by special request.

Speaker 1:

I am wearing the mullet. It's your rock and the mullet. Thank you, it looks really good. Appreciate that.

Speaker 2:

So anybody. But we do have it on video so people can watch as well. So, without further ado, why are you here at Vive and tell us a little bit about yourself.

Speaker 1:

Well, I am vibing because I'm obsessed with all things healthcare, and part of the solution that we've developed at the company that I'm at, ccs, incorporates a lot of digital health technologies and AI, and so it just made sense to be here and be here and learn and see what everybody else is doing. Are you up in the vendor hall as well, or are you just a guest in the? Are you up in the vendor hall as well, or are you just a guest in the? I'm just a guest.

Speaker 2:

Yeah, no, this is like I'm very skeptical about FOMO and I have to say people should legit have FOMO not being here, it's so much fun. It is a really fun. They put on a really good show. And people won't believe this because the pictures I'm posting make it look like I'm like this big have, I want to have a big fun time and put on the mullet and I'm so not like that. And they really put on a good show. So billy idol tonight. I know I mean, how do you beat that?

Speaker 2:

I know you can't beat that, I know people told us they were actually going to wear like mullet wigs, because anyways, we already have ours, can you?

Speaker 1:

can you tell us a little bit about your upcoming study? Is that okay? Yeah, so do you want to ask me about myself?

Speaker 2:

Yes, maybe I'll just start there.

Speaker 1:

So I'm the chief medical officer of CCS. I've been here for about a year and a half, okay, and I'm a board certified internist by background and spent most of my time on the healthcare industry side side, so I've been in healthcare services. I run my own business in healthcare services. I've been in med device. I spent time at a large payer where I led value-based care transformation in the home, I know nothing about that.

Speaker 2:

Oh my gosh, we're all about payment, transformation Our life, where we aren't just funding a podcast because we're passionate about it. We do a lot of work in value-based care, so we know that space very well, so keep going.

Speaker 1:

Yeah, so I was. I led value-based care transformation in the home. Okay, so not just home health, but also just high acuity care in the home and skilled nursing level care in the home. Nice and I joined CCS about a year and a half ago, and what drew me to CCS is that this is a company that had been around almost 30 years. We'll be 30 years, I think, in March or April this year, and it's it's the. The chassis is built on a distribution model for medical supplies, but what we learned in all these 30 years is that we have skyrocketing engagement. So you'll under you appreciate this from a value based care standpoint, but we have over 85% engagement. So you'll under you appreciate this from a value-based care standpoint, but we have over 85% engagement with our patients and our patients stay with us for over four years.

Speaker 2:

That's incredible.

Speaker 1:

So if I put my VBC payer hat on. Yeah, all I'm just doing this.

Speaker 2:

Absolutely Right. I'm like holy crap yeah.

Speaker 1:

Yeah, yeah. How do I make every interaction count, count? And one of the things that I wanted to talk about at Vive or it validated a lot of our thinking of what these patients with diabetes and chronic care conditions need.

Speaker 1:

So we know that we have high engagement. We know that we have a lot of touches with these patients. The next question is okay, are the solutions that we're building, are they actually going to make an impact? And are people going to welcome that? Because we can build whatever solution we want, but if the patients don't want that, and they don't want to engage it we're going to be twiddling our thumbs going.

Speaker 2:

Where is everybody?

Speaker 1:

And so what we did is we hired a third party survey company, pure Spectrum, and we got over 1,500 responses, and the population that we surveyed are individuals living with diabetes who also use a continuous glucose monitor or insulin pump. My mom, yep. So these are not healthy folks living with diabetes, because if you think about the medical necessity criteria for a continuous glucose monitor, these are not worried. Well, a touch of, as my patients like to say, I don't have diabetes, I just have sugar, or a touch of touch of sugar. Yeah, these are not a touch of sugar, these are complex folks, right that term worried well, worried well.

Speaker 1:

But 72% of the responders have multiple comorbidities in addition to diabetes, and so what we learn through this survey is Number one almost 40% of them said that they don't and didn't get the necessary information, education, support that they needed to actually manage their condition.

Speaker 2:

Absolutely so you've got a mom. I'm so excited we're going to have you on for a full episode. You haven't even said that. I think you said that today, but I'm telling you now. You have to come for a full episode.

Speaker 1:

You're never getting rid of me. How are you keeping a straight face with this going on? I'm pointing at my mullet, by the way, I hide my freak flag very well, I think.

Speaker 2:

But we bring it out, don't we? Yeah, for sure.

Speaker 1:

For sure. But so 40%, almost 40%, said they weren't getting. You know, they would get the device and they would get pamphlets, and I can attest to this, frankly, being a patient all last year. I'm sorry, handing somebody a booklet is not education to support because you're overwhelmed at the time of diagnosis and it's just hard, especially this population.

Speaker 1:

you're managing. How many doctors and subspecialists it's a lot to handle. And what was also interesting is that over 40% reported having a life-threatening emergency that took them to the ER and of those responders, 82% said that the ER visit was preventable if they just had somebody that could have helped them. So that tells us that there's a problem that we need to solve. What was really brought me hope, frankly, and just gave me got me really excited, is remember the reason I joined is like let's capitalize on that 85 percent engagement and all those touch points. And what we learned is that over 70 percent of the responders said that anybody touching them in the ecosystem during their health journey they would love for them to be more engaged in their health and have it be less transactional. And the best part about it is over 90% said that they would trust their supplier. So companies like us over 90% that they would trust their supplier to actually be a critical member of their care team.

Speaker 2:

Yeah well, we were just asked, Somebody just asked us and then we have to. We unfortunately have like two minutes left. I'm really sad, so we definitely have to do another episode, but like a full episode, because I want to hear. All about this is we actually had somebody ask us before about health care and like are people more skeptical now about health care, and especially after COVID? And Are people more skeptical now about health care and especially after COVID? And so it's really reassuring to hear you validate that. Like no, people still want the system to work, they still want caregivers. Right, and it's been validated. That's super exciting.

Speaker 1:

Yeah, they do, and they want to do it with people that they trust. Yeah, right, they're doctors, and then folks that they regularly engage with.

Speaker 2:

Yeah, All right, we have to go.

Speaker 1:

I'm really sad. We do so. Thank you so much for stopping by.

Speaker 2:

I can take this as a yes, you'll come back and do a full episode.

Speaker 1:

This is a hell. Yes, okay, that's a hell. Yes, all right, I love it. Hello, okay, all right, all right, thanks for taking time and you don't have to wear the wig every time. Thank you, I'm going to take it off right now. Thanks for stopping by. I appreciate it, thank you, thank you. You guys are the best.